Loading company…
Farmington Hills-based biopharmaceutical company developing therapies for eye disorders in ophthalmology.
Founded in 2018 and headquartered in Farmington Hills, US, Ocuphire Pharma develops treatments for ophthalmic conditions, including therapies aimed at improving vision and eye health. It sells to healthcare providers, specialized clinics and research institutions, mainly in North America and Europe, through partnerships and licensing agreements. CEO George Magrath co-leads the company with Mina Sooch. Its most recent funding was USD 2.13 mn on January 21, 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in